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REVIEW GROUP TYPE ACTIVITY FELLOWSHIP NUMBER 
SRC -7 
5 F31 HL08813-02 5 F31 BL08813-02 
NATIONAL INSTITUTES OF HEALTH, TOTAL AWARD PERIOD 
NHLBI-DEA 
GRANTS OPERATIONS BRANCH From: 10/01/92 Through: 09_1_30/95 
WESTWOOD BUILDING, BOOK 4A09A REQUESTED BUDGET PERIOD 
BETHESDA• MARYLAND 20892 
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To be verified by applicant. Check information in Items 1 through 6. If incorrect, furnish correct information in Item 11. 
1. TIT'E OF RESEARCH TRAINING PROPOSAL 
IKHIBITOR"S FOR COA.GULl'fiOM PRO'f!lS!S 
~~· rPLICANT (Name and address, street, city, state, zip code) 4. SPONSORING INSTITUTION (Name and address, street, city, 
¥"·-* 
state, zip code) 
~j BROWN• lUDRl D 
25694 GEORGIA TECH STATION GEORGIA !ECR RESEIRC:B CORP 
ATLANTA, Gl 30332 GEORGIA INS! 0! TI!CB 
-~ SCR OF CBEitiS TRY 
l'fLlNTl• Gl. 30332 
5. ENTITY IDENTIFICATION NUMBER 
15806031,6l1 
2b. SOCIAL SECURITY NUMBER 12c. HIGHEST DEGREE(S) 6. TITLE AND ADDRESS OF OFFICIAL~~ IR 
301-74-5813 BS SPONSqRING INSTITUTION BUSINESS OFFICE 
2d. DEPARTMENT, SERVICE, LABORATORY OR EQUIVALENT 
Jan1s Goddard 
CONTRACTING OFFICER 
SCHOOL JF :HEHISfRY & BIOCHEM GEORGIA TECH RES EARCB CORP 
2e. MAJOR SUBDIVISION G!ORGU I NSf OP ft:BlfOLOGY 
COLLEGE OF SCIENCES l!LlNTlt Gl 303 32-0420 
3. NAME OF SPONSOR 
POW ERSt Jl~ES c BITNET/INTERNET ADDRESS 
Complete the following (See instructions) iam~~ :6ic.h~mistrv i?atec.h edu 
7. HUMAN SUBJECTS { 0 Exemption# 10a. PERMANENT MAILING ADDRESS (Street, city, state, zip code) 
7a. 0 NO DYES OR 25694 Georgia Tech Station 
D lAB Approval Date Atlanta, Georgia 30332 
7b. Assurance of Compliance # 
8. VERTEBRATE ANIMALS 
Ba. ~NO D Yes ... IACUC Approval Date 
8b. Animal Welfare Assurance # 
9. TRAINING SITE(S) (Organizations and Addresses) 10b. APPLICANT'S TELEPHONE INFORMATION 
Area Code Phone number & extension 
OFFICE 404 894-4076 
FAX 404 894-7452 
HOME 404 953-1646 
PERMANENT 
404 953-1646 ADDRESS 
11. USE THIS SPACE FOR CORRECTIONS TO ITEMS 1 THROUGH 6. INDICATE THE NUMBER(S) WHERE ANSWERS APPLY. 
12. APPLICANT CERTIFICATION AND ACCEPTANCE: I certify that the statements herein are true, accurate, and complete to the best of my knowledge, 
and 1 agree to comply with Public Health Service terms and conditions if an award is issued as a result of this application. I certify that I have read the National 
Research Service Award Service Assurance, that I will abide by the Assurance if an award is made, and that the award will not support residency training. Willful 
provision of false information is a criminal offense (U.S. Code, Title 18, Section 1001). I am aware that any false, fictitious, or fraudulent statement may, in addition 
to other remedies available to the Government, subject me to civil penalties under the Program Fraud Civil Remedies Act of 1986 (45 CFR Part 79), 
IDATE 28 July 1993 
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PART I (Pages 1 and 2) 
FELLOWSHIP NUMBER . 
iNDIVIDUAL NATIONAL RESEARCH SERVICE AWARD 
CONTINUATION APPLICATION 
HL08813-02 
13. APPLICANT SUMMARY OF ACTIVITIES (Do not exceed 3 pages.) 
A. CHANGES . . rt' I r1 th h 
Since submission of the last application, have any significant changes occurred in the trammg program, P~ 1cu a Y e researc 
project, academic status, or time distribution of activities (i.e., percentage of time devoted to research project, course work, 
teaching, etc.)? If so, explain. 
B. PROGRESS REPORT . . . 
Describe concisely the research performed and research training obtained during the past year. L1st all courses and publications. 
C. RESEARCH TRAINING PLANS 
Describe concisely the research and research training planned for the requested budget period, including any course work. 
13. APPLICANT SUMMARY OF ACTIVITIES 
A. CHANGES 
Since submission of the last application, no significant changes have occurred in my 
training program. As stated in my original application, my time distribution was as follows: 20%, 
coursework; 5%, attending division and departmental seminars; 20%, preparation for the 
comprehensive exam; 45% research. The remaining 10%, originally planned for preparation of a 
seminar, was divided between coursework and research as necessary. The amount of time spent 
on research was divided as follows: 70%, the research project described in the original application; 
30%, an additional research project involved with kinetic studies of neutrophil elastase. 
B. PROGRESS REPORT 
Since October 1, 1992, the following peptide, a substrate for factor VITa, has been made by 
solid phase peptide synthesis. 




The reaction scheme for this synthesis is shown below: 
PHS 416-9 (Rev. 10/91) 
Fmoc-G--e 
Resin = 1 °/o Cross-linked Divinylbenzene-Styrene 
J:rAikoxybenzyl Alcohol Linker 
0.3-0.5 mmol/g, 200-400 mesh 
Fmoc-AA-OH 
0.4 M N-methyl morpholine in DMF 
20°/o piperidine in DMF 
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INDIVIDUAL NRSA APPLICATION 
CONTINUATION PAGE 
NAME OF APPLICANT (Last, first, middle initial) 
Brown, Audra D. 
Trt Mtr Trt Mtr tsu Boc 
Fmoc-b-P-~-~-G-~-~-L-~-~-1-V-G-G-~-k_yk-TG -e 
tsu Trt tsu Trt StBu Trt ! 20% piperidine in DMF (v/v) 
Trt Mtr Trt Mtr tsu Boc 
H2N-6-P-r-k-G-~-~-L -1-~-1-V -G-G-r-b-yJ~-G -8 
tsu Trt 1Bu Trt StBu Trt 
!89 :3:3:5 TF A:anisole :thioanisole:1 ,2-ethaned~hiol 
H2N-Q-P-E-R-G-N-N-L-T-R-l-V-G-G-Q-E-C-K-N-G-COOH 
The abbreviations that stem from the amino acids in this peptide represent the protecting 
groups on each residue. They are defined as follows: Trt, triphenymethyl; Mtr, 4-methoxy-2,3,6-
trimethylbenzylsulfonyl; tBu, tert.-butyl, Boc, tert.-butyloxycarbonyl; StBu, tert.-butylsulfenyl. 
The synthesis was done using a Rainin PS3 Petide Synthesizer that was purchased by the 
School of Chemistry and Biochemistry in the Spring of 1992. FMOC chemistry was used to 
accomplish the synthesis. The FMOC-amino acids were obtained from BACHEM California, and 
the common chemicals were obtained from either Aldrich or Sigma. Cleavage of the peptide from 
the resin was accomplished using 89% TFA, 5% 1,2-ethanedithiol, 3% anisole, and 3% 
thioanisole. Purification of this peptide by reverse phase HPLC has proven to be very difficult, 
and optimal conditions for purification as well as cleavage from the resin are currently being 
sought. 
The next phase of the project involves synthesis of a truncated sequence such that it has 12, 
14, 16, 18 and 20 amino acid residues. These substrates of different lengths will be used to 
assess the importance of various residues of the peptide in reaction with factor VITa. In addition, 
the fluoresecent-quench substrates will be synthesized. Methods for the synthesis of the amino 
acids containing the flourescent group and the quenching group are currently being researched in 
the literature. These substrates will be synthesized by the end of the calendar year 1993. 
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INDIVIDUAL NASA APPLICATION 
CONTINUATION PAGE 
NAME OF APPLICANT (Last, first, middle initial) 
Brown, Audra D. 
In addition to my research, I have taken the following courses: Structure of Proteins & Nucleic 
Acids, Molecular Biochemistry and a Special Topics class that covered Infrared Spectroscopy, 
Mass Spectra and Nuclear Magnetic Resonance Spectroscopy. The comprehensive exam was 
taken on June 28-29, 1993. The results are forthcoming. 
C. RESEARCH TRAINING PLAN 
The next budget period, October 1, 1993 - September 30, 1994 will be my third year of 
graduate school. I have completed my required coursework; however, I plan to audit two classes, 
Medicinal Chemistry and Biophysical Chemistry. During my third year, I will have to present a 
Biochemistry Divison Seminar and an original research proposal. I will spend approximately 10% 
of my time on each of these projects. Again, 5% of my time will be spent attending division and 
departmental seminars. The remainder of my time will be spent of research. 
PHS 416-1 (Rev. 4/89) Page _4......___ 
Part II 
INDIVIDUAL NATIONAL RESEARCH SERVICE AWARD 
CONTINUATION APPLICATION 
(To be completed by sponsor-follow Instructions) 
FELLOWSHIP NUMBER 
HL08813-02 
14. SUPPLEMENTATION OF FELLOW: D NO ~YES- If "yes," specify the amount(s) and dates on which 
supplementation occurred, and the source of the funds. 
15. COMMENTS OF SPONSOR (Use additional page, If necessary) 
A. Evaluate the quality of the training (including academic work) and research progress made by the fellow during the past year. 
Include performance on cumulative and qualifying examinations, If applicable. 
B. Human subjects and vertebrate animals (see instructions). 
14. The fellow was given a supplement of $295/month from a Miles, Inc. grant to carry out 
kinetic studies with human leukocyte elastase. The amount is the difference between the normal 
stipend of $13,000/year for chemistry graduate students and the amount provided by the NIH 
fellowship. 
15A. Audra Brown has been getting excellent grades in her recent courses. At the end of the 
spring quarter of 1993, she took the comprehensive exam in biochemistry. Her performance was 
marginal and the Biochemistry division agreed that she be given an oral exam at the time of her 
proposition (the second part of the comprehensive exam) sometime within the next year. 
Audra's research progress to date has been satisfactory, but quite slow. She works in the 
laboratory, is enthusiastic and interested in her research problem. I believe she needs to learn to 
budget her time more effectively, focus on research, and learn to ignore distractions which take 
her away from research. She has started the synthesis of a peptide inhibitor, but has yet to purify 
the peptide. She needs to obtain a command of the techniques for peptide synthesis. 
Audra has the stated goal of obtaining an academic position once she completes her Ph.D. 
degree. I agree that she is one of the few students each year with this potential. However she is 
still not performing at this level. She hasn't yet made the work commitment to reach for this 
goal, but I believe that she will do so shortly. 
15B. No human subjects or vertebrate animalsare involved in this research. 
Provide the number of subjects enrolled in the study to date according to the following categories (see Page 6 for definitions). 
American Indian 
or Alaskan Asian or Pacific Black, not of White, not of Other or 





16. CERTIFICATION. We, the undersigned, certify that: (a) the information herein, including involvement of Human Research Subjects, Recombinant DNA Research, 
and Vertebrate Animals, are true, accurate, and complete to the best of our knowledge; (b) if this application results in an award, appropriate training, adequate 
facilities, and supervision wilt be provided; and (c) we will comply with the Public Health Service terms and conditions of award. A willfully false certification is 
a criminal offense (U.S. Code Title 18, Section 1001). We are aware that any false, fictitious, or fraudulent statement may, in addition to other remedies available 
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Pi4S 416-9 (Rev. 10/91) 
TYPED NAME OFFICE TELEPHONE DATE 
James C. Powers ~404)894-4038 7/z7/93 
Loren M. Tolbert ~404)894-4002 1/!t!C?J 
f l 
Janis L. Goddard 404/894-4817 ? (3o (9) 
(Form Page 3) Page 5 
INDIVIDUAL NRSA CONTINUATION APPLICATION 
CHECKLIST 
FELLOWSHIP NUMBER 
Applicant completes Section I. Sponsor completes Section II. HL08813-02 
Section 1-Appllcant 
ASSURANCES/CERTIFICATIONS 
The following assurances/certifications are made by checking the appropriate boxes and are verified by your signature In Item 12 on the 
FACE PAGE of the application. Descriptions of Individual assurances/certifications begin on page 2 of the application Instructions. 
A. Debarment and Suspension 
B. Delinquent Federal Debt 
Section It-Sponsoring Institution 
~No 
r!J No 
DYes (Attach explanation) 
0 Yes (Attach explanation) 
The following assurances/certifications are made by checking the appropriate boxes and verified by the signature of the Official Signing for 
Sponsoring Institution in Item 16. Descriptions of sponsoring institution assu'i&nces/certlfications begin on page 7 of the application instructions. 
A. Human Subjects (Complete Item 7 on the Face Page) D Full IRB Review D Expedited Review 
Use of Human Subjects: D Change D No Change Since Previous Submission 
B. Vertebrate Animals (Complete Item 8 on the Face Page) 
Use of Vertebrate Animals: D Change D No Change Since Previous Submission 
C. Debarment and Suspension ~ No D Yes (Attach explanation) 
D. Misconduct in Science (Form PHS 6315) [X] Filed D Not Filed 
If filed, date of Initial Assurance or latest Annual Report. lLl4L92 
E. Civil Rights (Form HHS 441) [X) Filed D Not Filed 
F. Handicapped Individuals (Form HHS 641) Q Filed D Not Filed 
G. Sex Discrimination (Form HHS 639A) [Xl Filed D Not Filed 
H. Age Discrimination (Form HHS 680) rn Filed D Not Filed 
PHS 416-9 (Rev. 10/91) (Form Page 4) Page _6 __ 
